It was reported that the initial mitraclip procedure was performed on (b)(6) 2019 to treat degenerative mitral regurgitation (mr) with a grade of 4.One clip (cds0602-xtr, 90725u184) was implanted successfully reducing mr to 1-2.On (b)(6) 2019, the patient was re-admitted with shortness of breath and mr grade of 4.Echocardiogram was performed and showed the clip well attached to both leaflets, but tissue damage was noted.On (b)(6) 2019, a second mitraclip procedure was performed to treat tissue damage and reduce mr.One clip (cds0601-xtr, 90828u148) implanted successfully, but mr was not reduced.Mr remained at 4 due to quality of the vessel tissue.The vessel tissue was fragile.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The investigation was unable to determine a conclusive cause for the tissue damage.The recurrent mitral regurgitation (mr) appears to be related to the tissue damage and the mr likely resulted in the dyspnea; therefore, attributed to procedural conditions.The reported patient effects of tissue damage, mr and dyspnea as listed in the instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design, or labeling.
|